New clinical trial to test Paxlovid’s effectiveness against long COVID

Millions of people worldwide are suffering from often debilitating symptoms of long COVID that can persist weeks, months, or even years following an acute infection. But researchers are still in the dark on the mechanisms underlying and how to treat the mysterious post-viral syndrome. A new clinical trial using the oral antiviral Paxlovid will provide urgently needed insights for COVID long-haulers and their providers.

Leave A Comment

Your email address will not be published. Required fields are marked *